Systems and methods are disclosed that facilitate providing guidance to a user during performance of a program or routine using a personalized avatar. In an aspect, a system includes a reception component configured to receive biochemical information about a physiological state or condition of a user, including information identifying a presence or a status of one or more biomarkers. The system further includes an analysis component configured to determine or infer one or more characteristics of the physiological state or condition of the user based on the information identifying the presence or the status of the one or more biomarkers, and a visualization component configured to adapt an appearance of an avatar presented to the user based on the one or more characteristics to reflect the one or more characteristics.

Systems and methods are provided for performing a medical procedure within a patient's body that involves a thoracic duct including an ostium communicating with the patient's venous system. A distal end of a catheter is introduced through the patient's venous system into a body lumen adjacent the ostium of the thoracic duct. An expandable member on the distal end of the tubular member may be expanded adjacent the ostium, e.g., within the body lumen or the thoracic duct itself, and used to isolate the thoracic duct from the body lumen, whereupon a medical procedure may be performed via the thoracic duct. For example, lymphatic fluid may be removed from the thoracic duct through a lumen of the tubular member and/or one or more agents may be introduced into the thoracic duct through the tubular member.

A system and method for collecting symptomatic data to screen for a targeted disease. Testing hardware incorporates a plurality of testing units with corresponding indicators that can be altered to indicate whether a symptom is present or not. The resulting data from the testing use can then be analyzed to determine the likelihood of presence of a disease.

Exemplary methods are provided for real-time assessment of a potential risk of an infectious disease, including receiving a predetermined acceptable range for an aspect of a human user's physiological measurement data, receiving a predetermined acceptable answer for a survey response question, securely receiving an aspect of the human user's physiological measurement data, determining if the aspect of the human user's physiological measurement data is within the predetermined acceptable range, if the aspect of the human user's physiological measurement data is within the predetermined acceptable range, transmitting to the human user a survey comprising a question, if the aspect of the human user's physiological measurement data is not within the predetermined acceptable range, transmitting an active alert and not providing the human user with the survey comprising a question, and if the human user fails to transmit an acceptable answer to the survey comprising the question, transmitting an active alert.

The purpose of the invention is to provide rapid non contact detection of diseases, viruses, and other biological infections. A method of detecting diseases, viruses, and other biological infections is disclosed. The method comprises a gas analyzer detecting the chemical release emitted from a living body. The gas analyzer is an optical sensor and is located near the target. The gas analyzer then processes the readings using internal software to give an instant value of the concentration of the target gas. The gas analyzer would then output a signal indicating the presence of the gas. The gas analyzer can also incorporate a video camera for aiming purposes and recording images.

Systems and methods are disclosed that facilitate providing guidance to a user during performance of a program or routine using a personalized avatar. In an aspect, a system includes a reception component configured to receive biochemical information about a physiological state or condition of a user, including information identifying a presence or a status of one or more biomarkers. The system further includes an analysis component configured to determine or infer one or more characteristics of the physiological state or condition of the user based on the information identifying the presence or the status of the one or more biomarkers, and a visualization component configured to adapt an appearance of an avatar presented to the user based on the one or more characteristics to reflect the one or more characteristics.

Embodiments of the invention provide optimized polymeric surfaces adapted for use with implantable medical devices as well as methods for making and using such polymeric surfaces. These polymer surfaces have a constellation of features that function to inhibit or avoid an inflammatory immune response generated by implantable medical devices. Typical embodiments of the invention include an implantable glucose sensor used in the management of diabetes having a polymer surface with the disclosed constellation of features.

Manifestation of some physiological responses (e.g., stress, mental workload, or a headache) may involve the emergence of asymmetric thermal patterns on the face. Thus, thermal measurements of the face that are indicative of thermal asymmetry can be useful to detect such physiological responses. In one embodiment, a system includes first and second inward-facing head-mounted thermal cameras (CAM1 and CAM2, respectively) that are located less than 15 cm from the user's face, which take thermal measurements of regions on the right and left sides of the face (TH.sub.ROI1 and TH.sub.ROI2, respectively) of the user. The symmetric overlapping between the regions on the right and left sides (ROI.sub.1 and ROI.sub.2, respectively) is above 60%, and CAM1 and CAM2 do not occlude ROI.sub.1 and ROI.sub.2. Optionally, the system includes a computer that detects a physiological response based on thermal asymmetry between TH.sub.ROI1 and TH.sub.ROI2.

Manifestation of some physiological responses (e.g., stress, mental workload, or a headache) may involve the emergence of asymmetric thermal patterns on the face. Thus, thermal measurements of the face that are indicative of thermal asymmetry can be useful to detect such physiological responses. In one embodiment, a system includes first and second inward-facing head-mounted thermal cameras (CAM1 and CAM2, respectively) that are located less than 15 cm from the user's face, which take thermal measurements of regions on the right and left sides of the face (TH.sub.ROI1 and TH.sub.ROI2, respectively) of the user. The symmetric overlapping between the regions on the right and left sides (ROI.sub.1 and ROI.sub.2, respectively) is above 60%, and CAM1 and CAM2 do not occlude ROI.sub.1 and ROI.sub.2. Optionally, the system includes a computer that detects a physiological response based on thermal asymmetry between TH.sub.ROI1 and TH.sub.ROI2.

Due to the precautions put in place during the COVID-19 pandemic, utilization of telemedicine has increased quickly for patient care and clinical trials. Unfortunately, teleconsultation is closer to a video conference than a medical consultation with the current solutions setting the patient and doctor into a discussion that relies entirely on a two-dimensional view of each other. A telehealth platform is augmented by a digital twin of the patient that assists with diagnostic testing of ocular manifestations of myasthenia gravis. A hybrid algorithm combines deep learning with computer vision to give quantitative metrics of ptosis and ocular muscle fatigue leading to eyelid droop and diplopia. The system works both on a fixed image and video in real time allowing capture of the dynamic muscular weakness during the examination. The robustness of the system can be more important that the accuracy obtained in controlled conditions, so that the system and method can operate in practical standard telehealth conditions. The approach is general and can be applied to many disorders of ocular motility and ptosis.